CD274 and non-small cell lung carcinoma: However, even among the NSCLC patients with high levels of PD-L1 positivity, the objective response rate (ORR) is about 45%17,20, which might be due to defects in the entry or proliferation of tumor-infiltrating leukocytes or due to suppression by other molecular pathways in the TME.